Lupin 2024

The shifting profit pie: How earnings across the pharma sector are changing

The shifting profit pie: How earnings across the pharma sector are changing

How is the pharmaceutical value chain faring financially? Who are the biggest winners and losers? Every two years, Kearney analyzes pharmaceutical profit pools to answer those questions. Our analysis follows a drug across the value chain, from concept to patient. We aim to understand the profitability of key players in the U.S. value chain and

Drug makers and chains need a supply chain revamp

Drug makers and chains need a supply chain revamp

Does your supply chain keep you up at night? Due to ongoing market disruption, companies’ risk exposure has never been greater. Now is the time to design supply chains that can overcome risk today and thrive in the future. COVID-19 illustrated the vulnerability of supply chains to significant demand shifts and supply shocks caused by

PP_1170x120_10-25-21